First Affiliated Hospital Xi'an Jiaotong University
Clinical trials sponsored by First Affiliated Hospital Xi'an Jiaotong University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart signal test could spot valve disease faster Results expected Sep 2026 (estimated)
- Bile acid pill may shield against statin blood sugar side effect Results expected Nov 2026 (estimated)
- New CMV prevention drug could be safer for kidney transplant patients Results expected Nov 2026 (estimated)
- Can we predict psoriasis relapse after biologics? a new study digs into the clues. Results expected Dec 2026 (estimated)
- Blood fat clues could flag hidden heart rhythm risk Results expected Jan 2027 (estimated)
-
Can a single infusion fix a genetic cause of Sky-High cholesterol?
Cure Recruiting nowThis early trial tests a gene therapy called NGGT006 in people with homozygous familial hypercholesterolemia, a rare inherited condition causing extremely high LDL cholesterol and early heart disease. The therapy uses a harmless virus to deliver a working copy of the LDL receptor…
Early phase 1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
New stroke drug could boost recovery when given hours after symptoms
Disease control Recruiting nowThis phase 3 trial tests whether giving a clot-busting drug called rhPro-UK before a mechanical clot removal procedure improves recovery for people with severe stroke. About 820 participants who had a stroke 4.5 to 24 hours earlier will receive either the drug or a placebo, follo…
Phase 3 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Triple-Drug combo wipe out esophageal tumors before surgery?
Disease control Recruiting nowThis trial tests whether giving a combination of adebrelimab, famitinib, and chemotherapy before surgery can eliminate cancer cells in people with esophageal squamous cell carcinoma. The study enrolls 24 adults with resectable, locally advanced tumors. Participants receive two cy…
Phase 2 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could an ancient remedy cut early deaths in leukemia?
Disease control Recruiting nowThis study tests whether giving a Chinese herbal medicine called Realgar-Indigo naturalis formula (RIF) together with standard vitamin A therapy right away can lower the risk of early death in people with a fast-growing blood cancer called acute promyelocytic leukemia (APL). Abou…
Phase 3 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Bile acid pill may shield against statin blood sugar side effect
Prevention Recruiting nowThis study tests whether ursodeoxycholic acid (UDCA), a drug used for bile duct problems, can stop statins from raising blood sugar. 128 adults with high cholesterol but normal blood sugar will take either UDCA or a placebo alongside atorvastatin for 6 months. Researchers will tr…
Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New CMV prevention drug could be safer for kidney transplant patients
Prevention Recruiting nowThis study compares a new drug called leymovir to the standard drug valganciclovir for preventing cytomegalovirus (CMV) infection in 290 Chinese kidney transplant recipients. Leymovir targets a different part of the virus, which may reduce side effects like bone marrow suppressio…
Phase 4 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Heart fix may stop migraines: new trial tests Hole-Closing procedure
Symptom relief Recruiting nowThis study tests whether closing a small hole in the heart (called a PFO) can reduce migraine attacks and improve brain function. Researchers will compare 150 adults with migraines and a PFO who get the closure procedure to those who don't. The goal is to see if the procedure cut…
Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Blood fat clues could flag hidden heart rhythm risk
Knowledge-focused Recruiting nowThis study looks at whether certain fat molecules in the blood, called lipids and ceramides, are linked to atrial fibrillation, a common heart rhythm problem. Researchers will compare blood samples from people with atrial fibrillation to those with other heart conditions but no a…
Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Simple arm cuff routine may unlock Heart-Protective signals in the blood
Knowledge-focused Recruiting nowThis trial tests whether repeatedly inflating a blood pressure cuff on the upper arms to 200 mmHg for short cycles can trigger protective molecular changes in the blood of healthy adults aged 18 to 45. Participants are randomly assigned to receive the cuff cycles either once or t…
Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC